REFERENCE RANGE OF NT PRO BNP IN HEALTHY PREGNANT FEMALES
DOI:
https://doi.org/10.55629/pakjpathol.v34i3.769Abstract
Objective: To define the Reference Range of NT pro-BNP (N-terminal pro–B-type natriuretic peptide) during the first trimester of pregnancy in healthy females.
Material and Methods: This Cross-sectional study was conducted in the Department of Chemical Pathology, Combined Military Hospital, Lahore from September to November 2022. This cross-sectional study focused on the reference range of NT pro-BNP in healthy pregnant females. Sampling of the data was done by using the nonprobability consecutive sampling technique. A maximum number of available participants (365 pregnant females) during the study period were recruited. Descriptive statistics were shown as mean ±SD. For the reference range for NT pro-BNP 2.5th percentiles (lower limit) and 97.5th percentiles (upper limit) were estimated.
Results: A total of 365 pregnant females were included with first trimester pregnancy, having the mean age 28.54±5.18 years. Out of 365 participants, 299 females had BMI <25 whereas 66 were overweight. Forty-One females had Hb level ≤ 10 g/dl and 324 females had HB >10 g/dl. The Platelet count was >150 x 10^9/L in 338 women, and ≤150 x 10^9/L in 26 women. The Median of NT pro-BNP was 56.80 pg/mL in the first trimester. Reference range of NT pro-BNP in pregnant women with BMI <25 was (17.89 – 257.00) pg/mL as compared to (16.88 – 130.63) pg/mL in those with BMI >25.
Conclusion: The Reference range of NT pro-BNP changes in pregnancy as compared to healthy non-pregnant adults, likely due to hemodynamic changes associated with pregnancy. This study has defined a Pregnancy-specific reference range of NT pro-BNP in the first trimester which can help diagnose pregnant women with underlying cardiovascular disease.
Keywords: NT pro-BNP, Reference range, Pregnancy
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mariam Saeed, Muhammad Zeeshan Rana, Najeebullah Khan, Hina Anwar, Shakeel Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.